Theobald, M
Current immunotherapeutic strategies in cancerSpringer 2020 1 S.
Pielenhofer, Jonas; Sohl, Julian; Windbergs, Maike et al.
Current Progress in Particle-Based Systems for Transdermal Vaccine DeliveryFRONTIERS IN IMMUNOLOGY. Bd. 11. 2020
Weisel, Katja; Spencer, Andrew; Lentzsch, Suzanne et al.
Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic riskJOURNAL OF HEMATOLOGY & ONCOLOGY. Bd. 13. H. 1. 2020
Messerschmidt, Clemens; Obermayer, Benedikt; Klinghammer, Konrad et al.
Distinct immune evasion inAPOBEC-enriched,HPV-negativeHNSCCINTERNATIONAL JOURNAL OF CANCER. Bd. 147. H. 8. 2020 S. 2293-2302
Viardot, Andreas; Hess, Georg; Bargou, Ralf C. et al.
Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphomaLEUKEMIA & LYMPHOMA. 2020
Faehling, Martin; Schumann, Christian; Christopoulos, Petros et al.
Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP)LUNG CANCER. Bd. 150. 2020 S. 114-122
Kadioglu, Onat; Saeed, Mohamed E. M.; Munder, Markus et al.
Effect of ABC transporter expression and mutational status on survival rates of cancer patientsBIOMEDICINE & PHARMACOTHERAPY. Bd. 131. 2020
Huang, Kui; Madison, Terri; Wehler, Beatrice et al.
Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non-small cell lung cancer (NSCLC) in EuropePHARMACOLOGY RESEARCH & PERSPECTIVES. Bd. 8. H. 2. 2020
Buhl, Roland; FitzGerald, J. M.; Meltzer, Eli O. et al.
Efficacy of once-daily tiotropium Respimat in adults with asthma at GINA Steps 2-5PULMONARY PHARMACOLOGY & THERAPEUTICS. Bd. 60. 2020
Buhl, Roland; de la Hoz, Alberto; Xue, Wenqiong et al.
Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naive to LAMA, LABA and ICS: Pooled Analysis of Four Clinical TrialsADVANCES IN THERAPY. 2020